Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar 24;12(3):1690-8.
doi: 10.3390/md12031690.

New and rare carotenoids isolated from marine bacteria and their antioxidant activities

Affiliations
Review

New and rare carotenoids isolated from marine bacteria and their antioxidant activities

Kazutoshi Shindo et al. Mar Drugs. .

Abstract

Marine bacteria have not been examined as extensively as land bacteria. We screened carotenoids from orange or red pigments-producing marine bacteria belonging to rare or novel species. The new acyclic carotenoids with a C₃₀ aglycone, diapolycopenedioc acid xylosylesters A-C and methyl 5-glucosyl-5,6-dihydro-apo-4,4'-lycopenoate, were isolated from the novel Gram-negative bacterium Rubritalea squalenifaciens, which belongs to phylum Verrucomicrobia, as well as the low-GC Gram-positive bacterium Planococcus maritimus strain iso-3 belonging to the class Bacilli, phylum Firmicutes, respectively. The rare monocyclic C₄₀ carotenoids, (3R)-saproxanthin and (3R,2'S)-myxol, were isolated from novel species of Gram-negative bacteria belonging to the family Flavobacteriaceae, phylum Bacteroidetes. In this review, we report the structures and antioxidant activities of these carotenoids, and consider relationships between bacterial phyla and carotenoid structures.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The structures of diapolycopenedioc acids A (1), B (2) and C (3).
Figure 2
Figure 2
The structure of methyl 5-glucosyl-5,6-dihydro-apo-4,4′-lycopenoate (4).
Figure 3
Figure 3
The structures of (3R)-saproxanthin (5) and (3R,2′S)-myxol (6).

References

    1. Britton G., Liaaen-Jensen S., Pfander H. Carotenoids Handbook. Birkhäuser Verlag; Basel, Switzerland: 2004.
    1. Nishino H., Tokuda H., Murakoshi M., Satomi Y., Masuda M., Onozuka M., Yamaguchi S., Takayasu J., Tsuruta J., Okuda M., et al. Cancer prevention by natural carotenoids. Biofactors. 2000;13:89–94. doi: 10.1002/biof.5520130115. - DOI - PubMed
    1. Iwamoto T., Hosoda K., Hirano R., Kurata H., Matsumoto A., Miki W., Kamiyama M., Itakura H., Yamamoto S., Kondo K. Inhibition of low-density lipoprotein oxidation by astaxanthin. J. Atheoscler. Thomb. 2000;7:216–222. - PubMed
    1. Krinsky N.I., Landrum J.T., Bone R.A. Biological mechanism of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr. 2003;23:171–201. doi: 10.1146/annurev.nutr.23.011702.073307. - DOI - PubMed
    1. Naito Y., Uchiyama K., Aoi W., Hasegawa G., Nakamura N., Yoshida N., Maoka T., Takahashi J., Yoshikawa T. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors. 2004;20:49–59. doi: 10.1002/biof.5520200105. - DOI - PubMed